SKI Market

A+| A| A-|

Indian Indices

Sensex

78,151.45 964.58
( 1.25%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shree Ganesh Biotech India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539470

INE051N01026

1.5963013

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

21.53

EPS(TTM)

Face Value()

Div & Yield %

0.01

Back

Balrampur Chini Mills consolidated net profit declines 30.36% in the March 2026 quarter

May 16,2026

Net profit of Balrampur Chini Mills declined 30.36% to Rs 159.57 crore in the quarter ended March 2026 as against Rs 229.12 crore during the previous quarter ended March 2025. Sales rose 6.67% to Rs 1603.99 crore in the quarter ended March 2026 as against Rs 1503.68 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.38% to Rs 378.46 crore in the year ended March 2026 as against Rs 436.92 crore during the previous year ended March 2025. Sales rose 15.80% to Rs 6271.15 crore in the year ended March 2026 as against Rs 5415.38 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	1603.99	1503.68	7	6271.15	5415.38	16
OPM %	17.76	24.29	-	11.82	13.00	-
PBDT	280.86	354.83	-21	737.33	734.79	0
PBT	236.17	311.70	-24	560.15	562.25	0
NP	159.57	229.12	-30	378.46	436.92	-13

78,151.45 964.58 ( 1.25%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)